FDA reconsiders artificial intelligence use after commissioner departure, focusing on ai strategy and implementation, while ensuring regulatory compliance.
FDA reconsiders artificial intelligence use after commissioner departure, focusing on ai strategy and implementation, while ensuring regulatory compliance.
Johnson & Johnson’s Ottava surgical robot gains FDA clearance, boosting precision in general surgery and challenging da Vinci’s…
Medtronic invests $37M in CoreMap to advance cardiac mapping technology for precise AFib treatment, improving ablation outcomes.
Boston Scientific trims 2026 sales and earnings guidance due to slowing growth in key product lines, including Watchman…
Abbott launches a comprehensive heart valve study assessing its TriClip device's real-world safety and performance in treating tricuspid…
Boston Scientific restructuring plan will incur up to $800 M in pre‑tax charges as the company shifts production…
Prevent drug diversion with multidisciplinary auditing and procurement checks beyond diversion surveillance software effectively.
Ravulizumab trial results reveal no significant improvement in event‑free survival for HSCT‑TMA patients, highlighting challenges in this rare…
Discover the latest guidance on switching disease-modifying therapies for multiple sclerosis patients, focusing on hit-hard-and-early treatment era strategies…
Regular coffee intake is linked to lower disease risk, with up to 400 mg of caffeine daily considered…
